Douglas N. Nguyen

Learn More
Multiple subcutaneous immunoglobulin (SCIG) products are available to treat primary antibody deficiency (PAD). The efficacy and tolerability of 16% SCIG (Vivaglobin(®) ) was compared with 20% SCIG (Hizentra(®) ) in PAD subjects. The study was a prospective, single-centre, open-label study of PAD subjects transitioning Vivaglobin to equivalent Hizentra(More)
RATIONALE To determine the general utility of clinical (Asthma Control Test) and physiologic (forced expiratory volume in the first second of exhalation [FEV(1)] and fractionated exhaled nitric oxide level [FeNO]) parameters for characterizing asthma patients. METHODS Two cross-sectional independent studies simultaneously enrolled 100 patients in the US(More)
Hepatitis C virus (HCV) infection is one of the most common causes of chronic liver disease in the world and represents a substantial burden on global health systems and individual patient wellbeing. Routine screening for HCV in certain high-risk populations is appropriate. HCV can cause both an acute and chronic hepatitis, and manifests as a variety of(More)
This document explains NT roaming profile issues experienced on public PC's at Bethel College & Seminary. Issues explained include slow login times (5+ minutes), profile corruption, and lost files. It also explains the NT logon and logoff process. This document is for user services and support staff to come up with a plan to help users overcome these(More)
  • 1